Pfizer Recalls Bubble Gum-Flavored Children’s Advil

Mismatched dosage cups and overdose concerns have prompted a voluntary recall of Children’s Advil Suspension.

Recalled Children's Advil / Image: Arizona's Family
Recalled Children's Advil / Image: Arizona's Family

A recent Today article noted the recall of a lot of bubble gum-flavored Children’s Advil suspension medicine. Action was taken after Pfizer, maker of the medicine, received complaints from consumers who noticed a discrepancy between the instructions and the packaging. Apparently the 4-ounce bottles were packaged with cups marked in teaspoons, while the instructions contained measurements in millimeters.

Pfizer hasn’t mentioned whether or not there have been any reports of injury, but they did release a statement noting the most common symptoms associated with ibuprofen overdose, which include nausea, vomiting, headache, drowsiness, blurred vision, and dizziness.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026